AC IMMUNE SA (ACIU) Stock Income Statement
NASDAQ:ACIU - Nasdaq - CH0329023102 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 28.30M | 27.31M | 14.80M | 3.90M | 0.00 | |||
| Operating Expenses | 79.98M | 79.69M | 68.42M | 74.80M | 79.00M | |||
| Research and Development | 63.32M | 62.57M | 54.61M | 60.30M | 62.30M | |||
| Selling, General, and Administrative Expenses | 11.57M | 11.43M | 10.58M | 9.60M | 10.90M | |||
| Operating Income | -51.68M | -52.38M | -53.62M | -70.80M | -79.00M | |||
| Interest Income/Expense | -400.00K | 1.47M | -599.00K | 100.00K | 6.00M | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | 0.00 | |||
| Income Before Taxes | -52.08M | -50.91M | -54.22M | -70.70M | -73.00M | |||
| Income Tax | 3.00K | 3.00K | 10.00K | 0.00 | 0.00 | |||
| Net Income | -52.08M | -50.92M | -54.23M | -70.80M | -73.00M | |||
| EBITDA | -49.46M | -50.22M | -51.41M | -68.44M | -76.59M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.52 | -0.51 | -0.64 | -0.85 | -0.97 | |||
| Non GAAP EPS | -0.53 | -0.52 | -0.64 | -0.85 | -0.99 | |||
| Statistics | ||||||||
| Profit Margin | -184.05% | -186.44% | -366.41% | -1815.38% | N/A | |||
| Operating Profit Margin | -182.62% | -191.80% | -362.30% | -1815.38% | N/A | |||
All data in CHF